CONTOUR® NEXT GEN 血糖监测系统
K号: K223293 · 2022-11-18
广告
器械摘要
常见问题
What is the CONTOUR® NEXT GEN Blood Glucose Monitoring System?
CONTOUR® NEXT GEN Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2022-11-18. The listed applicant is Ascensia Diabetes Care U.S., Inc.. The 510(k) number is K223293.
When did CONTOUR® NEXT GEN Blood Glucose Monitoring System receive FDA 510(k) clearance?
CONTOUR® NEXT GEN Blood Glucose Monitoring System received FDA 510(k) clearance on 2022-11-18, under 510(k) number K223293.
Who is the listed applicant for CONTOUR® NEXT GEN Blood Glucose Monitoring System?
The FDA 510(k) record lists Ascensia Diabetes Care U.S., Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CONTOUR® NEXT GEN Blood Glucose Monitoring System?
The FDA product code for CONTOUR® NEXT GEN Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Ascensia Diabetes Care U.S., Inc.为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:NBW)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告